Evidence map›Paper›PMID 39738572›Full record

ArticleAbdominal radiology (New York)2025

A novel artificial intelligence segmentation model for early diagnosis of bladder tumors.

Lu Li, Lingxiao Jiang, Kun Yang, Bin Luo, Xinghuan Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lu LiZhongnan Hospital of Wuhan University, Wuhan, China.
Lingxiao JiangZhongnan Hospital of Wuhan University, Wuhan, China.
Kun YangZhongnan Hospital of Wuhan University, Wuhan, China.
Bin LuoWuhan University, Wuhan, China. luob@whu.edu.cn.
Xinghuan WangZhongnan Hospital of Wuhan University, Wuhan, China. Wangxinghuan1966@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDespite cystoscopy plays an important role in bladder tumors diagnosis, it often falls short in flat cancerous tissue and minuscule satellite lesions. It can easily lead to a missed diagnosis by the urologist, which can lead to a swift tumor regrowth following transurethral resection of the bladder tumor (TURBT). Therefore, we developed a deep learning-based intelligent diagnosis system for early bladder cancer to improve the identification rate of early bladder tumors.

methodsVideo data from 273 bladder cancer patients who underwent TURBT at Zhongnan Hospital were collected. The dataset was carefully annotated by urologists to clearly define tumor boundaries. Subsequently, we developed a new bladder tumor segmentation network (BTS-Net) based on transformer to accurately diagnose early-stage bladder cancer lesions.

resultsOur experiments demonstrate that the BTS-Net we developed has outperformed other method on the external B validation dataset, achieving a MPrecision of 91.39%, a MRecall of 95.71%, a MIoU of 88.18% and an F1-score of 93.18%. The BTS-Net showed high accuracy with real-time processing speed at 23 fps.

conclusionMissed detection of satellite lesions in early bladder tumors often leads to tumor recurrence. Our BTS-Net is capable of segmenting all potential satellite lesions in surgical videos, without the need for complex professional equipment. This AI-assisted diagnosis system has the potential to improve surgical outcomes by ensuring comprehensive treatment of all tumor-related areas during TURBT.

Indexed as

Artificial IntelligenceDeep LearningEarly Detection of CancerImage Interpretation, Computer-AssistedUrinary Bladder NeoplasmsAgedCystoscopyFemaleHumansMaleMiddle AgedRetrospective StudiesArtificial intelligenceBladder tumorDeep learningEarly diagnosisSegmentation anything model

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.